A pathological classification for predicting recurrence and guiding adjuvant therapy in esophageal squamous cell carcinoma following neoadjuvant immunochemotherapy: a two-center cohort study

BackgroundNeoadjuvant immunochemotherapy (nICT) has emerged as a promising treatment modality for locally advanced esophageal squamous cell carcinoma (ESCC). However, optimal post-nICT adjuvant strategies remain undefined, and a classification system that integrates both prognosis and recurrence pat...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Jiaming Huang, Hongsheng Xie, Guiqing Zeng, Manhong Yao, Zhifeng Zhang, Zhekai Zhang, Qijun Zheng
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2026-03-01
Σειρά:	Frontiers in Oncology
Θέματα:	adjuvant therapy chemotherapy esophageal squamous cell carcinoma neoadjuvant immunotherapy pathological response recurrence pattern
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1778731/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!